I remember that many HC posters were outraged when VLA’s board supported the takeover by Merck for $500m (or $1.70 a share which was also a 170% premium). But obviously it was unanimously approved by shareholders i.e the magical 90% mark.
my point is that I think you’d see the scenario here if there was a similar scenario. We’d be disappointed that it wasn’t more - but I don’t think many people would turn down almost tripling their money overnight
The biggest premium over the past five years for a biotech takeover was the 290% premium sanofi paid for synthorx
No one can forget of course Gilead’s $US21 billion takeover of immunomedics end of last year
Media, page-88
-
- There are more pages in this discussion • 656 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.015(4.92%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.5¢ | 30.0¢ | $1.168M | 3.702M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 148547 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 51809 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |